Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald T Nepom

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Cellular Immunology|July 30, 2017
Looking behind the data curtainGerald T Nepom, David Scott
Clinical Immunology (Orlando, Fla.)|March 30, 2004
MHC Class II tetramers and the pursuit of antigen-specific T cells: define, deviate, deleteRoberto Mallone, Gerald T Nepom
Journal of Autoimmunity|March 8, 2016
Obstacles and opportunities for targeting the effector T cell response in type 1 diabetesJane H Buckner, Gerald T Nepom
Current Opinion in Immunology|July 31, 2012
A functional framework for interpretation of genetic associations in T1DGerald T Nepom, Jane H Buckner
Clinical Immunology (Orlando, Fla.)|April 15, 2008
A nexus of science and clinical immunology: the Federation of Clinical Immunology Societies and the FOCIS Centers of ExcellenceMichael T Lotze, Gerald T Nepom
The Review of Diabetic Studies : RDS|June 28, 2013
Immune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experienceMario R Ehlers, Gerald T Nepom
Nature Immunology|March 29, 2002
Class II peptide multimers: promise for type 1A diabetes?George S Eisenbarth, Gerald T Nepom
Current Opinion in Rheumatology|May 1, 2002
Genetics of rheumatoid arthritis: is there a scientific explanation for the human leukocyte antigen association?Jane H Buckner, Gerald T Nepom
Journal of Immunological Methods|October 24, 2006
A real-time PCR approach for rapid high resolution subtyping of HLA-DRB1*04Vivian H Gersuk, Gerald T Nepom
Immunity|April 24, 2010
Prediction and pathogenesis in type 1 diabetesAnette-G Ziegler, Gerald T Nepom
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Cellular Immunology|July 30, 2017
Looking behind the data curtainGerald T Nepom, David Scott
Clinical Immunology (Orlando, Fla.)|March 30, 2004
MHC Class II tetramers and the pursuit of antigen-specific T cells: define, deviate, deleteRoberto Mallone, Gerald T Nepom
Journal of Autoimmunity|March 8, 2016
Obstacles and opportunities for targeting the effector T cell response in type 1 diabetesJane H Buckner, Gerald T Nepom
Current Opinion in Immunology|July 31, 2012
A functional framework for interpretation of genetic associations in T1DGerald T Nepom, Jane H Buckner
Clinical Immunology (Orlando, Fla.)|April 15, 2008
A nexus of science and clinical immunology: the Federation of Clinical Immunology Societies and the FOCIS Centers of ExcellenceMichael T Lotze, Gerald T Nepom
The Review of Diabetic Studies : RDS|June 28, 2013
Immune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experienceMario R Ehlers, Gerald T Nepom
Nature Immunology|March 29, 2002
Class II peptide multimers: promise for type 1A diabetes?George S Eisenbarth, Gerald T Nepom
Current Opinion in Rheumatology|May 1, 2002
Genetics of rheumatoid arthritis: is there a scientific explanation for the human leukocyte antigen association?Jane H Buckner, Gerald T Nepom
Journal of Immunological Methods|October 24, 2006
A real-time PCR approach for rapid high resolution subtyping of HLA-DRB1*04Vivian H Gersuk, Gerald T Nepom
Immunity|April 24, 2010
Prediction and pathogenesis in type 1 diabetesAnette-G Ziegler, Gerald T Nepom
Pageof 14